What are CNS Embryonal Tumors ?

We are providing comprehensive information on medulloblastoma and other CNS embryonal tumors in children, including their causes, symptoms, diagnosis, staging, treatment, prognosis, and management.

CNS embryonal tumors are high-grade (fast-growing) malignant brain tumors that develop from early developmental cells in the central nervous system. Medulloblastoma is the most prevalent embryonal CNS tumor, one that happens to account for a significant fraction of brain tumors classified as high-grade malignancies in children. Other, rare or less common types of embryonal tumors include:

• CNS embryonal tumor, NOS (not otherwise specified)
• CNS embryonal tumor with multilayered rosettes (ETMR)
• Atypical teratoid/rhabdoid tumor (AT/RT)
• Formerly classified as primitive neuroectodermal tumors (PNETs)

These tumors occur mainly in children, especially those under the age of 10 years.

What is Medulloblastoma?

Medulloblastoma is a malignant brain tumor that emerges in the cerebellum, the lower back part of the brain responsible for coordination and balance. It is marked by the following features:

• High growth rate
• Potential for dissemination via cerebrospinal fluid
• Potential for metastasis to the spinal cord

Medulloblastoma is not a single disease. Recent advances in research have revealed that there are various molecular subtypes of medulloblastoma, which include:

• WNT-activated
• SHH-activated
• Group 3
• Group 4

Who is at Risk for CNS Embryonal Tumors ?

CNS embryonal tumors mainly occur in:

• Children aged 3 to 8 years.
• Boys are slightly more than girls.
• Uncommonly in adolescents.

Most instances occur randomly, with no known reason. But certain genetic syndromes raise the chance, such as:

• Gorlin syndrome
• Li-Fraumeni syndrome
• Turcot syndrome

In most cases, no known environmental factors are present.

What are the Symptoms and Causes CNS Embryonal Tumors?

Symptoms of CNS Embryonal Tumors

Since these cancers develop rapidly and often occur in the cerebellum, symptoms often include increased intracranial pressure and balance problems. The symptoms often include:

• Headaches
• Vomiting in the morning
• Nausea
• Balance problems
• Trouble walking
• Double vision
• Slurred speech
• Weakness
• Irritability in young children
• Increased head size in infants

If the cancer metastasizes to the spinal cord, symptoms may include:

• Back pain
• Weakness in the legs
• Changes in bowel or bladder habits

Causes of CNS Embryonal Tumors

These tumors arise from abnormal genetic mutations in developing brain cells. The main causes are:

• Genetic mutations in signaling pathways (WNT, SHH)
• Tumor suppressor gene mutations
• Disordered cell cycle control

Most genetic mutations are spontaneous during cell development. In some cases, genetic syndromes are passed down from parents.

How are CNS Embryonal Tumors Diagnosed and Tested ?

Early and accurate diagnosis is essential.

• 1. Neurological Examination: The following are the tasks in the Physician's assessment: Balance, Reflexes, Muscle strength, Eye movements, Coordination.
• 2. Imaging Studies (MRI): Brain MRI is the gold standard. It shows: Size of tumor, Site, Pattern of involvement of the brain. Spinal MRI is essential for determining metastasis.
• 3. Surgery & Biopsy: Surgical excision of the tumor is done whenever feasible. The excised tissue is studied to confirm: Tumor type, Histopathology, Molecular subgroup. Molecular analysis is necessary for treatment planning.
• 4. Lumbar Puncture: Cerebrospinal fluid analysis is done to identify tumor cells and the extent of disease.

How is Staging and Risk Stratification Determined ?

Staging is based on:

• Residual tumor following surgery
• Presence of metastatic disease
• Molecular phenotype

Patients are classified as:

• Standard-risk
• High-risk

Risk stratification guides treatment intensity.

What are the Management and Treatment Options for CNS Embryonal Tumors ?

Chemotherapy, radiation, and surgery are all part of the treatment.

• 1. Surgery: The initial approach is surgical excision aiming at total safe tumor removal, with the objectives to: remove all tumor tissue from the patient; release all existing pressure; collect tissue samples for medical diagnosis. Complete tumor removal is associated with better survival rates for patients.
• 2. Radiation Therapy: Radiation therapy is essential for children over 3 years of age. The treatment methods include: Craniospinal irradiation (CSI); Tumor bed boosts radiation. Standard-risk patients receive lower doses of radiation to minimize late toxicity. Radiation therapy in children under 3 years of age is often deferred or reduced to avoid developmental toxicity.
• 3. Chemotherapy: Multi-drug chemotherapy treatment is administered after surgery and radiotherapy. The drugs used are: Cisplatin, Vincristine, Cyclophosphamide, Etoposide. Chemotherapy treatment aims at: Elimination of any residual tumor cells; Decrease recurrence risk; Enable dose reduction of radiation.
• 4. High-Dose Chemotherapy with Stem Cell Rescue: This is an option in high-risk or recurrent disease.
• 5. Other CNS Embryonal Tumors: Other types of embryonal tumors may need: Aggressive chemotherapy; Radiation therapy; Targeted therapy in clinical trials. AT/RT and ETMR may need more aggressive treatment.

What are the Side Effects of Treatment of CNS Embryonal Tumors ?

Short-term side effects:

• Hair loss
• Nausea and vomiting
• Increased risk of infection
• Weakness

Long-term side effects:

• Learning problems
• Hormonal imbalance
• Hearing loss
• Growth delay
• Second cancers

What is the Outlook / Prognosis of CNS Embryonal Tumors ?

Survival rates depend on the type and risk group. For medulloblastoma:

• Standard-risk patients: 70-85% survival rate
• High-risk patients: 50-70% survival rate

The WNT subtype has an excellent prognosis, often with a survival rate of >90%. The prognosis is worse for Group 3 patients.

• Early diagnosis
• surgical excision of the tumor
• and treatment increase the chances of survival.

What Care and Survival Support is Needed in the Long Term for CNS Embryonal Tumors ?

Children will need lifelong care and follow-up services in the following areas:

• Cognitive development
• Hormone management
• Auditory system
• Psychological adjustment

Care services include:

• Neuropsychological assessment
• Educational services
• Rehabilitation therapy
• Counseling

Family support is a vital part of recovery.

When should Parents Seek Medical Attention for CNS Embryonal Tumor Diagnosed child ?

If a kid has any of the following, parents should get medical help right away:

• Chronic vomiting in the morning
• Balance problems
• Severe headaches
• Sudden changes in vision
• Unexplained weakness
• Seizures

Early treatment can make a big difference.

Why choose Tender Palm Super-Speciality Hospital for Medulloblastoma and Other CNS Embryonal Tumor Treatment in Lucknow, India?

Tender Palm Super-Speciality Hospital offers advanced CNS Embryonal Tumor treatment in Lucknow, India, at an affordable cost. We have a team of experienced neurosurgeons and neuro-oncology specialists who provide accurate diagnosis and both surgical and non-surgical treatment options including tumor resection, radiation therapy, and chemotherapy. Our Neurosurgery and Neuro-Oncology team has decades of experience in successfully treating CNS Embryonal Tumor in Lucknow, India.

To seek an Expert consultation for Medulloblastoma and Other CNS Embryonal Tumor Treatment in Lucknow, India:

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back